[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Mitomycin C Market Data Survey Report 2025

September 2017 | 87 pages | ID: GB7B864030BEN
HeyReport

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

The global Mitomycin C market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Average market price by SUK

Major applications

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
  • Kyowa-kirin
  • Intas Pharmaceuticals
  • Teva
  • Bristol-Myers Squibb
  • Aspen
  • Speciality European Pharma
  • Alkem Laboratories
  • Varifarma
  • APOGEPHA

Major applications as follows:
  • Cancer Treatment
  • Ophthalmic Use
  • Others
Regional market size, production data and export & import:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.4 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Kyowa-kirin
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Intas Pharmaceuticals
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Teva
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Bristol-Myers Squibb
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Aspen
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Speciality European Pharma
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Alkem Laboratories
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Varifarma
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 APOGEPHA
  3.9.1 Company Information
  3.9.2 Product Specifications
  3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Cancer Treatment
  4.1.1 Overview
  4.1.2 Cancer Treatment Market Size and Forecast
4.2 Ophthalmic Use
  4.2.1 Overview
  4.2.2 Ophthalmic Use Market Size and Forecast
4.3 Others
  4.3.1 Overview
  4.3.2 Others Market Size and Forecast

5 MARKET PRICE

5.1 Overview
5.2 Price by SUK

6 CONCLUSION

LIST OF TABLES

Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Kyowa-kirin
Tab Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of Aspen
Tab Sales Revenue, Volume, Price, Cost and Margin of Speciality European Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Alkem Laboratories
Tab Sales Revenue, Volume, Price, Cost and Margin of Varifarma
Tab Sales Revenue, Volume, Price, Cost and Margin of APOGEPHA
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)

LIST OF FIGURES

Fig Global Mitomycin C Market Size and CAGR 2011-2017 (Value)
Fig Global Mitomycin C Market Size and CAGR 2011-2017 (Volume)
Fig Global Mitomycin C Market Forecast and CAGR 2018-2025 (Value)
Fig Global Mitomycin C Market Forecast and CAGR 2018-2025 (Volume)
Fig Cancer Treatment Market Size and CAGR 2011-2017 (Value)
Fig Cancer Treatment Market Size and CAGR 2011-2017 (Volume)
Fig Cancer Treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Cancer Treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Ophthalmic Use Market Size and CAGR 2011-2017 (Value)
Fig Ophthalmic Use Market Size and CAGR 2011-2017 (Volume)
Fig Ophthalmic Use Market Forecast and CAGR 2018-2025 (Value)
Fig Ophthalmic Use Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025


More Publications